Netramark Holdings Inc (TSE:AIAI) has released an update.
NetraMark Holdings Inc. has bolstered its advisory board with the appointment of pharmaceutical industry veteran Jeff Huntsman, bringing over 30 years of expertise to enhance the company’s AI-driven solutions in precision medicine. Huntsman’s background in commercial and operational leadership is expected to significantly contribute to NetraMark’s growth and commercialization strategies. NetraMark specializes in AI and Machine Learning solutions tailored to the pharmaceutical industry, aiming to optimize clinical trials and market access solutions.
For further insights into TSE:AIAI stock, check out TipRanks’ Stock Analysis page.
